The Third Circuit further noted, “The conduct that allegedly caused plaintiffs’ injuries is the same conduct forming the basis of the RICO scheme alleged in the complaint – the misrepresenta... Read more
Following concerns that it hid important clinical data on Avandia, drug maker GlaxoSmithKline (GSK) has now agreed to share more clinical data. GSK was recently fined for withholding safety... Read more
The British drug company GlaxoSmithKline has agreed to pay $3 billion to settle United States government civil and criminal investigations into its sales practices for numerous drugs. The se... Read more
A U.S. District Court in Pennsylvania has ruled that updated product warnings concerning the diabetes drug Avandia may not have adequately warned users of the risks of heart attack and strok... Read more
A federal medical advisory panel recommended last month that the diabetes drug, Avandia, should either be withdrawn from the market or have sales severely restricted because it increases the... Read more
Thank you for choosing to receive The Jere Beasley Report, a comprehensive summary of national and state political and legal news. Penned by Beasley Allen founding shareholder Jere L. Beasle... Read more
Nearly 700 people, all of whom are suing drug maker GlaxoSmithKline in three separate lawsuits alleging severe adverse events connected with the diabetes medication Avandia, are settling wit... Read more
Elderly people with diabetes who took the controversial drug rosiglitazone, sold under the brand name Avandia, were more likely to develop congestive heart failure and more likely to die tha... Read more
Since a meta-analysis was made public in May 2007, Avandia, GlaxoSmithKline’s diabetes drug, has come under fire. The meta-analysis showed the medicine was increasing the risk of heart... Read more
We are constantly being asked about what is going on in our firm’s Mass Torts Section. Lawyers in the Section are currently investigating a number of drugs and medical devices, and are... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.